Cancer BiologyCancersPeer-reviewed
DNA Polymerase Beta Catalytic and Fidelity Mutations Drive Platinum Specific Drug Sensitivity
Jacob Lindquist, Joshua R. Heyza, Istri Ndoja…·Steve M. Patrick
This study identifies Polβ mutations that drive sensitivity to cisplatin and carboplatin in TNBC models, suggesting their use as predictive biomarkers for platinum-based therapies.
DOI 10.3390/cancers18162531